Dr. Lisa Danzig, Chief Medical Advisor at CETF, discusses a clinical trial that has identified a new COVID-19 treatment called Fluvoxamine. Bloomberg Businessweek Editor Joel Weber and Businessweek Economics Editor Peter Coy talk about the $120 billion idea behind this year’s Nobel Prize in economics. We get Businessweek Economics with Bloomberg Economics Senior U.S. Economist Yelena Shulyatyeva. She shares her insight on fiscal stimulus. And we Drive to the Close with Lesley Marks, Chief Investment Officer and Head of Investment Management at BMO Private Wealth.
Hosts: Carol Massar and Paul Sweeney. Producer: Doni Holloway.
See omnystudio.com/listener for privacy information.
